dipyridamole has been researched along with Hypophosphatemia in 5 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Hypophosphatemia: A condition of an abnormally low level of PHOSPHATES in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaya, B | 1 |
| Altun, E | 1 |
| Paydas, S | 2 |
| Balal, M | 2 |
| Seyrek, N | 1 |
| Sertdemir, Y | 1 |
| Karayaylali, I | 1 |
| Hoshino, C | 1 |
| Satoh, N | 1 |
| Sugawara, S | 1 |
| Kuriyama, C | 1 |
| Kikuchi, A | 1 |
| Ohta, M | 1 |
| Michaut, P | 1 |
| Prié, D | 2 |
| Amiel, C | 1 |
| Friedlander, G | 2 |
| Blanchet, FB | 1 |
| Essig, M | 1 |
| Jourdain, JP | 1 |
2 trials available for dipyridamole and Hypophosphatemia
| Article | Year |
|---|---|
Dipyridamole for renal phosphate leak in successfully renal transplanted hypophosphatemic patients.
Topics: Administration, Oral; Adult; Dipyridamole; Drug Administration Schedule; Female; Humans; Hypophospha | 2005 |
Dipyridamole decreases renal phosphate leak and augments serum phosphorus in patients with low renal phosphate threshold.
Topics: Administration, Oral; Adult; Dipyridamole; Drug Administration Schedule; Female; Glomerular Filtrati | 1998 |
3 other studies available for dipyridamole and Hypophosphatemia
| Article | Year |
|---|---|
The efficacy of dipyridamole in the treatment of hypophosphatemia- hypocalcemia for hungry bone syndrome in a hemodialysis patient.
Topics: Adult; Bone Diseases, Metabolic; Dipyridamole; Female; Humans; Hyperparathyroidism, Secondary; Hypoc | 2015 |
Sporadic adult-onset hypophosphatemic osteomalacia caused by excessive action of fibroblast growth factor 23.
Topics: Age of Onset; Bone Density Conservation Agents; Dipyridamole; Fibroblast Growth Factor-23; Fibroblas | 2008 |
Dipyridamole for renal phosphate leak?
Topics: Adult; Aged; Dipyridamole; Female; Humans; Hypophosphatemia; Male; Middle Aged; Phosphates | 1994 |